Revance Therapeutics
Presence
Revance Therapeutics is one of the...
Revance Therapeutics is a company listed under the stock ticker RVNC (US).
Executives
View the org chart displaying its 19 main executives
Most searched biographies at Revance Therapeutics
- Mark Foley, President, Chief Executive Officer and Director
- Chris Nolet, Director
- Carey O'Connor Kolaja, Director
Popular executive movements at Revance Therapeutics
- Erica Jordan, who was Senior Vice President Commerical Strategy, is promoted to Chief Commercial Officer, Aesthetics (posted on November 9 2023).
Create your alert
to follow the executive moves at Revance Therapeutics.
Pharmaceuticals
Revance Therapeutics has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Revance Therapeutics
- Revance to Release Second Quarter 2022 Financial Results on Tuesday, August 9, 2022 - Revance Therapeutics, Inc.
- Revance To Present Clinical Data on DaxibotulinumtoxinA for Injection at the 2022 TOXINS International Conference - Revance Therapeutics, Inc.
- Revance to Participate in the William Blair 42nd Annual Growth Stock Conference - Revance Therapeutics, Inc.
- Revance Reports First Quarter 2022 Financial Results, Provides Corporate Update - Revance Therapeutics, Inc.
- Revance to Release First Quarter Financial Results on Tuesday, May 10, 2022 - Revance Therapeutics, Inc.
- Revance to Present Three New Abstracts Evaluating DaxibotulinumtoxinA for Injection and Two ePosters Evaluating the RHA® Collection During the American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting - Revance Therapeutics, Inc.
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Revance Therapeutics, Inc.
- Revance to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference - Revance Therapeutics, Inc.
- Revance to Participate in the Wells Fargo Securities Healthcare Conference - Revance Therapeutics, Inc.
- Revance Commercial Infrastructure Established and Positioned to Launch Prestige Aesthetics Portfolio with the RHA® Collection of Dermal Fillers - Revance Therapeutics, Inc.
- View more press releases Close
Social media about Revance Therapeutics
- Revance Therapeutics on Wikipedia, Google News & Yahoo Finance
- Revance Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mark Foley 
Call Revance Therapeutics at +1 510...
